Amphastar pharmaceuticals reports q2 flat gaap earnings

Amphastar pharmaceuticals reports financial results for the three months ended june 30, 2020.q2 gaap earnings per share $0.00.q2 revenue $85.8 million versus refinitiv ibes estimate of $86.6 million.q2 adjusted non-gaap earnings per share $0.16.q2 earnings per share estimate $0.14 -- refinitiv ibes data.

AMPH Ratings Summary

AMPH Quant Ranking